These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 5132112

  • 21. Distribution and properties of amino acid decarboxylases in gastric mucosa.
    Håkanson R, Owman C.
    Biochem Pharmacol; 1966 Apr; 15(4):489-99. PubMed ID: 5954981
    [No Abstract] [Full Text] [Related]

  • 22. Hypothalamic secretion of dopamine after inhibition of aromatic L-amino acid decarboxylase activity.
    Reymond MJ, Porter JC.
    Endocrinology; 1982 Oct; 111(4):1051-6. PubMed ID: 6811255
    [Abstract] [Full Text] [Related]

  • 23. Automated radiometric assays of enzymatic and nonenzymatic oxidation of DOPA in vitro.
    Tran N.
    J Lab Clin Med; 1974 Aug; 84(2):287-91. PubMed ID: 4843233
    [No Abstract] [Full Text] [Related]

  • 24. [Action of some DOPA decarboxylase inhibitors with reference to different types of convulsions].
    HEROLD M, CAHN J, HELBECQUE C, KABACOFF O.
    C R Seances Soc Biol Fil; 1962 Aug; 156():1273-6. PubMed ID: 13954030
    [No Abstract] [Full Text] [Related]

  • 25. Properties of a new system of amine-storing cells in the gastric mucosa of the rat.
    Håkanson R, Lilja B, Owman C.
    Eur J Pharmacol; 1967 May; 1(3):188-99. PubMed ID: 6058905
    [No Abstract] [Full Text] [Related]

  • 26. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I, Bartholini G, Tissot R, Fletscher A.
    J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
    [No Abstract] [Full Text] [Related]

  • 27. [Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
    Geissbühler F, Constantinidis J, Eisenring JJ, Krassoievitch M, Yanniotis G, Tissot R.
    Clin Chim Acta; 1971 Jun; 33(1):111-5. PubMed ID: 5097993
    [No Abstract] [Full Text] [Related]

  • 28. Effect of L-aromatic amino acid decarboxylase inhibition on metabolism of dihydroxyphenylalanine by isolated perfused rat liver.
    Tyce GM, Owen CA.
    Biochem Pharmacol; 1972 Nov 15; 21(22):2977-89. PubMed ID: 4649349
    [No Abstract] [Full Text] [Related]

  • 29. Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.
    Bianchine JR, Sunyapridakul L.
    Drugs; 1973 Nov 15; 6(5):364-88. PubMed ID: 4787755
    [No Abstract] [Full Text] [Related]

  • 30. Effects of peripheral aromatic L-amino acids decarboxylase inhibitor on L-(2- 14 C)-3,4-dihydroxyphenylalanine metabolism in man.
    Messiha FS, Hsu TH, Bianchine JR.
    Biochem Pharmacol; 1972 Aug 01; 21(15):2144-7. PubMed ID: 4645885
    [No Abstract] [Full Text] [Related]

  • 31. How does L-dopa work in parkinsonism?
    Sandler M.
    Lancet; 1971 Apr 17; 1(7703):784. PubMed ID: 4101278
    [No Abstract] [Full Text] [Related]

  • 32. Central decarboxylation and uptake of L-DOPA.
    Andén NE, Engel J, Rubenson A.
    Naunyn Schmiedebergs Arch Pharmacol; 1972 Apr 17; 273(1):11-26. PubMed ID: 4260798
    [No Abstract] [Full Text] [Related]

  • 33. Metabolism of putative transmitters in individual neurons of Aplysia californica: aromatic amino acid decarboxylase.
    Weinreich D, Dewhurst SA, McCaman RE.
    J Neurochem; 1972 Apr 17; 19(4):1125-30. PubMed ID: 4401683
    [No Abstract] [Full Text] [Related]

  • 34. Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylation.
    Pletscher A, Bartholini G.
    Clin Pharmacol Ther; 1971 Apr 17; 12(2):344-52. PubMed ID: 5577483
    [No Abstract] [Full Text] [Related]

  • 35. Properties of human red blood cell 1-3,4-dihydroxyphenylalanine decarboxylating activity.
    Dairman W, Christenson JG.
    Eur J Pharmacol; 1973 May 17; 22(2):135-40. PubMed ID: 4736669
    [No Abstract] [Full Text] [Related]

  • 36. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
    Ng KY, Colburn RW, Kopin IJ.
    Nature; 1971 Apr 02; 230(5292):331-2. PubMed ID: 5549411
    [No Abstract] [Full Text] [Related]

  • 37. Catechol- and indolamines in some endocrine cell systems. An autoradiographical, histochemical and radioimmunological study.
    Tjälve H.
    Acta Physiol Scand Suppl; 1971 Apr 02; 360():1-122. PubMed ID: 4933514
    [No Abstract] [Full Text] [Related]

  • 38. Relative penetration of L-dopa and 5-HTP through the brain barrier using dimethyl sulfoxide.
    De la Torre JC.
    Experientia; 1970 Oct 15; 26(10):1117-8. PubMed ID: 5312418
    [No Abstract] [Full Text] [Related]

  • 39. Variations in aromatic amino acid decarboxylase activity towards DOPA and 5-hydroxytryptophan caused by pH changes and denaturation.
    Bender DA, Coulson WF.
    J Neurochem; 1972 Dec 15; 19(12):2801-10. PubMed ID: 4652630
    [No Abstract] [Full Text] [Related]

  • 40. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase.
    Wurtman RJ, Watkins CJ.
    Nature; 1977 Jan 06; 265(5589):79-80. PubMed ID: 834247
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.